###begin article-title 0
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Expression of the Na+/l- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
The sodium/iodide symporter (NIS) is a plasma membrane glycoprotein that mediates iodide (I-) transport in the thyroid, lactating breast, salivary glands, and stomach. Whereas NIS expression and regulation have been extensively investigated in healthy and neoplastic thyroid and breast tissues, little is known about NIS expression and function along the healthy and diseased gastrointestinal tract.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 164 172 <span type="species:ncbi:9606">patients</span>
Thus, we investigated NIS expression by immunohistochemical analysis in 155 gastrointestinal tissue samples and by immunoblot analysis in 17 gastric tumors from 83 patients.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 246 265 246 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori</italic>
###xml 246 265 <span type="species:ncbi:210">Helicobacter pylori</span>
Regarding the healthy Gl tract, we observed NIS expression exclusively in the basolateral region of the gastric mucin-producing epithelial cells. In gastritis, positive NIS staining was observed in these cells both in the presence and absence of Helicobacter pylori. Significantly, NIS expression was absent in gastric cancer, independently of its histological type. Only focal faint NIS expression was detected in the direct vicinity of gastric tumors, i.e., in the histologically intact mucosa, the expression becoming gradually stronger and linear farther away from the tumor. Barrett mucosa with junctional and fundic-type columnar metaplasia displayed positive NIS staining, whereas Barrett mucosa with intestinal metaplasia was negative. NIS staining was also absent in intestinalized gastric polyps.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
That NIS expression is markedly decreased or absent in case of intestinalization or malignant transformation of the gastric mucosa suggests that NIS may prove to be a significant tumor marker in the diagnosis and prognosis of gastric malignancies and also precancerous lesions such as Barrett mucosa, thus extending the medical significance of NIS beyond thyroid disease.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 446 448 446 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 470 472 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 707 709 707 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 804 806 804 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 957 958 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1234 1235 1234 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1342 1345 1342 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1348 1350 1348 1350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1350 1351 1350 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1379 1381 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1384 1385 1384 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 295 301 <span type="species:ncbi:9606">humans</span>
Iodide (I-) is an essential constituent of the thyroid hormones triiodothyronine (T3) and tetraiodothyronine (T4). These hormones are vital for the normal development and maturation of the central nervous system in the newborn and for multiple metabolic functions in the adult. I- metabolism in humans appears to have adapted to provide sufficient I- for normal thyroid function in the face of the environmental scarcity of I-. A cornerstone of I- metabolism is active I- uptake in the thyroid, a process mediated by the sodium/iodide symporter (NIS)[1,2]. NIS is an integral plasma membrane glycoprotein located in the basolateral membrane of the thyroid follicular cells[3]. Although NIS-mediated active I- uptake has long been viewed as a distinctly thyroidal phenomenon, it is now clear that active I- transport observed in extrathyroidal tissues such as salivary glands, lactating mammary gland, gastric mucosa, and placenta is also mediated by NIS [3-8]. The NIS cDNA cloned from these tissues is identical to thyroid NIS[5]. Indeed, deglycosylation with N-glycosidase F or methionine-specific CNBr cleavage of thyroid, stomach, and mammary gland NIS proteins has indicated that NIS is the same protein in each of these tissues[6]. NIS-mediated radioiodide uptake in the stomach and salivary glands is routinely observed in radioiodide/99mTcO4 -whole-body scintiscans (Fig 1A) [9].
###end p 11
###begin p 12
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 125 127 125 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 332 334 332 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 394 404 394 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">secretion </italic>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 444 446 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 544 545 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 572 574 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 642 644 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 713 715 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 813 815 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 911 913 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1032 1033 1032 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The supply of I- for thyroid hormone biosynthesis is governed by dietary I- intake, I- absorption, and thyroidal I- uptake. I- is presumed to be absorbed in the small intestine, but neither the anatomical location of its absorption nor its mechanism has been identified. Interestingly, gastric NIS mediates the active transport of I- from the bloodstream to the gastric lumen, i.e., the active secretion of I- into the gastric juice. Secreted I- is then recirculated into the bloodstream when it is absorbed, along with newly ingested dietary I-, in the small intestine. I- is ultimately excreted mainly by the kidneys. The role of secreted I- in the gastric juice is unknown, as is the function of NIS-mediated I- secretion to the saliva in the salivary glands. By contrast, the functional role of NIS-mediated I- translocation in the lactating mammary gland is crucial and very clear: the process results in I- secretion to the milk, thus supplying the anion to the breast-fed newborn for his/her own thyroid hormone biosynthesis[6].
###end p 12
###begin p 13
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 442 448 442 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 883 885 883 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 903 906 903 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 909 911 909 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 995 997 995 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1065 1071 1065 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1188 1191 1188 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1194 1196 1194 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1196 1197 1196 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1363 1364 1363 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1367 1370 1367 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1373 1375 1373 1375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1375 1376 1375 1376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1400 1402 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1403 1405 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1454 1460 1454 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1465 1468 1465 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1471 1473 1471 1473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1473 1475 1473 1475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1616 1619 1616 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1622 1624 1622 1624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1624 1625 1624 1625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1667 1669 1667 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1670 1672 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
Data on NIS expression and function in regions of the gastrointestinal tract other than the stomach are still scant and somewhat controversial. The presence of the NIS transcript, as detected by RT-PCR, has been reported in both the colon[10] and the small intestine[11]. However, other investigators have been unable to amplify the NIS transcript in either of these two tissues[5,12,13]. By immunoshistochemistry, Spitzweg et al[5], Lacroix et al [13], and Wapnir et al [14] have observed some NIS protein expression in the colon; in contrast, Vayre et al [15] observed it only in the rectum but not in the rest of the colon. None of the investigations carried out to date have shown NIS expression in the esophagus[3]. Findings on NIS expression in gastrointestinal tumors have also been limited. Gastric carcinoma, unlike normal mucosa, has generally been reported to exhibit no I- or pertechnetate (99mTcO4 -)accumulation [16-18] (pertechnetate is an anion with the same size and charge as I- and is similarly transported by NIS), with the sole exception of Wu et al [19], who reported radioiodide uptake in gastric adenocarcinoma. In addition, in the 1960's and 70's, radioiodide or 99mTcO4 -gastric scintigraphy was studied as a possible method for the diagnosis of gastric neoplasia, based on the finding that malignant gastric tissue failed to transport I-or 99mTcO4 -into the gastric juice [16-18]. Furthermore, during the same decade, Berquist et al used 99mTcO4 - scintigraphy to establish the diagnosis of Barrett esophagus, based on the characteristic replacement of the distal esophageal mucosa by the 99mTcO4 -concentrating gastric columnar epithelium[20,21]. These observations suggest not only that NIS expression may be impaired as a result of malignant transformation, but also that the determination of NIS expression and function may be of diagnostic value in gastroesophageal disease.
###end p 13
###begin p 14
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
Consistent with the above concept is our recent report of decreased or absent NIS expression in 27 gastric adenocarcinomas studied by high-density tissue microarrays[14]. Whereas tissue microarrays are optimal for high-throughput screening, the sampling with tissue cores is limited Thus, to expand our findings and more thoroughly examine the issue of NIS expression in gastroesophageal cancer and its possible diagnostic value, we have analyzed NIS expression in normal and malignant gastrointestinal tissue samples from 83 patients. Samples were obtained during surgical resection or endoscopic examination and were analyzed by immunohistochemistry on conventional tissue sections, given that this technique offers the advantage (over RT-PCR) of determining expression and cellular localization of the NIS protein instead of the NIS transcript[22]. We also assessed NIS expression by immunoblot analysis to ascertain the specificity of the observed immunoreactivity.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
Snap frozen tissue samples were obtained for immunoblot analysis from 17 patients undergoing resections for gastric tumors (3 MALT and 14 adenocarcinomas from 5 female and 12 male patients; average age: 62). Corresponding normal peritumoral tissues were also collected.
###end p 16
###begin p 17
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
We studied by immunohistochemistry tissue samples obtained from the gastrointestinal tracts of 66 patients (average age: 54; male/female ratio: 37/29). In the case of 20 cancer patients, samples were taken from tumors and their neighboring areas (tumor, tumor margin, and 1 cm and more than 3 cm from the tumor margin) immediately after resection in the operating theatre; the remaining 46 (66-20) were biopsies. Tissue samples from small and large intestines were obtained from all segments of the intestinal tract (jejunum, ileum, and right and left colon). Permission for the investigation was obtained from the local Ethical Committee of the St. George University Teaching Hospital Szekesfehervar, Hungary.
###end p 17
###begin title 18
Immunoblot
###end title 18
###begin p 19
###xml 429 431 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 516 518 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 685 687 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 739 740 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 741 743 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 718 723 <span type="species:ncbi:9606">human</span>
###xml 808 819 <span type="species:ncbi:3704">horseradish</span>
###xml 838 844 <span type="species:ncbi:9793">donkey</span>
###xml 850 856 <span type="species:ncbi:9986">rabbit</span>
Tissue samples were blended for 1 min with a polytron homogenizer (Brinkman Instruments, Westbury, New York) and homogenized with a stirrer type glass-Teflon homogenizer (Caframo-Wiarton, Ontario, Canada) in a buffer containing 250 mM sucrose, 1 mM EDTA, 10 mM Hepes (pH 7.5), and protease inhibitors (90 mug/ml aprotinin, 4 mug/ml leupeptin, 0.8 mM phenylmethanesulfonyl fluoride). Membrane fractions were prepared as described[23]. PAGE and electroblotting to nitrocellulose were performed as previously described[23]. All samples were diluted 1:2 with sample buffer and heated at 37degreesC for 30 min prior to electrophoresis. Immunoblot analysis was also carried out as described[23], with affinity-purified anti-human-NIS (-hNIS) Ab[6,14] (1 mug/mul) at a 1:2,000 dilution, and a 1:2,000 dilution of a horseradish-peroxidase-linked donkey anti-rabbit IgG (Amersham). Both incubations were performed for 1 h. Proteins were visualized by the enhanced chemiluminescence (ECL) Western blot detection system (Amersham).
###end p 19
###begin title 20
Immunohistochemistry
###end title 20
###begin p 21
###xml 304 305 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 306 308 305 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 592 594 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 488 493 <span type="species:ncbi:9606">human</span>
All gastrointestinal tissue sections (3 mum) were deparaffinated and rehydrated. All slides were subjected to antigen retrieval by means of a 10%-citrate buffer. Washes were done with TBST [0.3 M NaCI, 0.1% Tween 20, 0.05 M Tris-HCI (pH 7.6)] for 5 min. Endogenous peroxide activity was blocked with 5% H2O2 for 15 min. Endogenous biotin activity was blocked with the DAKO Biotin Blocking System (Carpinteria, CA). Slides were incubated for 1 h with the affinity-purified polyclonal anti-human NIS antibody generated against the last 16 amino acids of the carboxy-terminal end of the protein[22]. The initial concentration of the Abs was 1 mug/mul; they were diluted in the blocking solution 1:6,000. The Catalyzed Signal Amplification kit (DAKO, Carpinteria, CA) was used for the remainder of the procedure according to the supplier's instructions. Salivary parotid gland was used as a positive control and mesenteric lymph node as a negative control. All slides were counterstained with hematoxylin.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C,D</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E,F</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G,H</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 625 628 <span type="species:ncbi:10116">rat</span>
Immunohistochemical analysis of NIS in the thyroid, salivary glands, and stomach revealed very distinctly in which particular cells NIS is located in each tissue, namely the thyroid epithelial (Fig. 1C,D), salivary gland ductal epithelial (Fig. 1E,F), and gastric mucin-producing epithelial cells (Fig. 1G,H). In all three kinds of cells, NIS is clearly observed in the basolateral plasma membrane. By immunoblot analysis of membrane fractions, human NIS was detected mainly as a fully glycosylated mature ~90-120-kDa polypeptide in thyroid, salivary gland, and stomach (Fig. 1B and Fig. 2). We have previously shown that in rat tissues, NIS differences in electrophoretic mobility are due to different degrees of glycosylation[6]. The partially glycosylated ~50-kDa-precursor band and the ~180-kDa-dimer band observed in thyroid tissue were also detected in salivary glands and in the stomach upon longer exposure.
###end p 23
###begin p 24
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
We investigated NIS protein expression by immnunoblot analysis in 17 gastric tumors (3 MALT and 14 adenocarcinomas) and in their corresponding peritumoral normal tissues. Twelve tumors (71%) exhibited no NIS expression and 5 (29%) of the tumoral tissues showed significantly decreased NIS expression compared to that of normal gastric mucosa (Table 1). Six peritumoral tissues displayed NIS expression similar to that of normal mucosa, 4 exhibited weak expression, and 7 lacked NIS expression altogether. No MALT lesions displayed NIS staining; interestingly, the normal mucosa in close proximity of the tumor was also negative (Table 1 and Fig. 2).
###end p 24
###begin p 25
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G,H</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3m</xref>
###xml 987 995 987 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b,q,t,w</xref>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
To gain further insight into NIS expression in the digestive tract, we analyzed NIS by immunohistochemistry in samples from different patients. A total of 155 tissue samples obtained from the gastrointestinal tracts of 66 patients (Table 2) was studied, including 42 esophageal, 53 gastric, 11 small-bowel, and 49 large-bowel tissue samples. NIS expression was detected only in the gastric mucosa. More specifically, we observed NIS expression in the basolateral region of normal gastric mucosal surface epithelial cells in the form of expressed, homogenous linear staining (Figs. 1G,H; and 3m). At the same time, we detected no NIS expression in the mucin-containing cells of the neck of the foveola, in the parietal and chief cells, or in the neuroendocrine cells. Similarly, the goblet, Paneth, and ciliated epithelial cells of gastric intestinal metaplasia, as well as the mucus-producing columnar cells of the colon and the squamous esophageal epithelium, proved NIS negative (Fig. 3b,q,t,w).
###end p 25
###begin p 26
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3i&#8211;q</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G,H</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3k,I</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3m</xref>
NIS expression was absent in gastric cancer, independently of its histological type [adenocarcinoma (n = 4), signet-ring cell (n = 3), papillary (n = 1) and (Fig. 3i-q)]. NIS expression was undetectable along the tumor margins in more than half the cases and weakly focally present in the remaining instances (Table 3). Even at a distance of 1 cm from the tumor margin, NIS staining was weak and focal in all cases in contrast to that in normal gastric mucosa (Figs. 2G,H and 3k,I). The characteristic linear plasma membrane expression pattern was detected only far from the tumor (Fig. 3m), indicating that NIS expression is lost in the vicinity of the cancer.
###end p 26
###begin p 27
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3n,o</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3p,q</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c,d</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e,f</xref>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
Nine out often hyperplastic gastric polyps were NIS-positive (Fig. 3n,o), the only negative being a colon-type metaplasia (Fig. 3p,q). The findings in samples from patients with Barrett esophagus were striking: five junctional and fundus-type columnar metaplasias were NIS positive (Fig. 3c,d), whereas five showing intestinal metaplasia were consistently negative (Fig. 3e,f).
###end p 27
###begin p 28
###xml 122 142 122 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 122 141 <span type="species:ncbi:210">Helicobacter pylori</span>
The samples from patients with gastritis displayed NIS expression independently of the presence (4/6) or absence (2/6) of Helicobacter pylori (Table 2).
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 431 433 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 639 641 639 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 719 721 718 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 721 722 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 872 873 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 874 876 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 877 879 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 985 986 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1084 1085 1083 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1086 1088 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1089 1091 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1092 1094 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1115 1121 1114 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1122 1124 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1257 1263 1256 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1264 1266 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The field of extrathyroidal I- transport has changed considerably since the extensive review published on the topic in 1961 by Brown-Grant. The main vertebrate nonthyroid tissues reported to accumulate I- actively via NIS are the salivary glands, gastric mucosa, lactating mammary gland, placenta, choroid plexus, and ciliary body of the eye[3,4,8,24]. With the exception of the lactating mammary gland, the physiological role of I- or other anions transported by NIS in extrathyroidal tissues is unknown. These tissue-specific NIS-mediated transport systems exhibit functional similarities to their thyroid counterpart, such as a Km for I- ranging from 10 to 30 muM and susceptibility to inhibition by perchlorate (CIO4 -). In contrast to TSH-regulated thyroid NIS and lactationally regulated mammary gland NIS, both salivary and gastric NIS are constitutively expressed[6,25,26]. NIS has been detected in the basolateral membrane of all ductal epithelial cells in the salivary gland[6], and in the basolateral membrane of superficial mucin-secreting epithelial cells in the stomach[6,13,15,27]. Although Spitzweg et al [27] reported NIS-specific immunostaining in parietal cells, we observed NIS expression exclusively in surface epithelial cells. Wapnir et al [14] have reported some NIS expression in a limited number of colon samples, but no NIS expression in colon was detected in the present study by either immunohistochemistry or immunoblot (not shown). There are at least three possible explanations for this discrepancy: NIS expression may be focal rather than widespread along the large bowel, variations in fixation methods may alter tissue antigenicity, or microarray overstaining may result from the "edge effect" of the small tissue cores.
###end p 30
###begin p 31
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 95 97 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 109 111 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 123 125 121 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 125 126 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 137 139 135 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 139 141 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 148 150 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 189 191 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 331 333 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 553 554 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 567 569 565 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 569 570 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 656 658 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 658 659 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 805 807 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 808 810 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 833 835 831 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 835 837 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 861 870 859 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 871 873 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 920 921 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 946 948 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 951 961 949 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 1069 1071 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1121 1123 1119 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1123 1125 1121 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1217 1226 1215 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 1417 1427 1415 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 861 870 <span type="species:ncbi:210">H. pylori</span>
###xml 951 960 <span type="species:ncbi:210">H. pylori</span>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
###xml 1217 1226 <span type="species:ncbi:210">H. pylori</span>
###xml 1337 1345 <span type="species:ncbi:9606">patients</span>
###xml 1417 1426 <span type="species:ncbi:210">H. pylori</span>
NIS transports other anions with the following relative apparent affinities: I- (1.00) >/= SeCN- (0.87) > SCN- (0.34) > CIO3 -(0.12) > NO3 - (0.04)[28]. As indicated earlier, the roles of I- or other anions secreted to the lumen of the gastrointestinal system by the constitutively expressed salivary and gastric NIS are unknown. I- concentrated in the gastric juice is reabsorbed in the small intestine and used for thyroid hormone biosynthesis by the thyroid or excreted by glomerular filtration through the kidney. Albeit with a lower affinity than I-, nitrate (NO3 -) is one of the other anions transported by NIS. Nitrate can be reduced to nitrite (NO2 -) by facultative anaerobic bacteria, and it can be acidified in the stomach, generating nitric oxide (NO), which has a strong bactericidal effect[29,30]. Indeed, acidified NO2 - is bactericidal against H. pylori[31]; this effect is amplified by thiocyanate (SCN-), another NIS substrate[32]. H. pylori is frequently found in patients with gastric ulcers, suggesting a possible causative role for this bacteria[33]. Thus, one may speculate that if NIS-mediated NO3 - secretion occurs in the stomach, NIS function might play a role in containing or preventing H. pylori-linked gastric ulcers or chronic gastritis. However, we observed no changes in NIS expression in samples from patients with gastritis as compared to normal subjects, irrespective of whether H. pylori was present.
###end p 31
###begin p 32
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 295 300 <span type="species:ncbi:9606">human</span>
NIS expression and function have been investigated in both thyroid and breast cancers. Whereas NIS expression is absent or decreased in 30% of thyroid cancers, NIS is actually overexpressed but not properly targeted to the plasma membrane in the remaining 70%[14,22]. Significantly, over 70% of human breast cancers express NIS, raising the prospect of the possible use of radioiodide in the diagnosis and treatment of breast cancer[6], as is routinely and successfully done in the treatment of NIS-expressing thyroid cancer.
###end p 32
###begin p 33
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
We ascertained NIS expression in gastrointestinal tumors by carrying out immunohistochemical analysis on biopsies obtained from 66 patients, partly during surgical interventions and partly during endoscopical examinations. In addition, 17 surgical samples were investigated by immunoblot analysis. We detected no NIS staining in patients with intestinalization or gastric cancer, indicating that malignant transformation is linked to decreased or suppressed NIS expression. Interestingly, the focal NIS staining observed in the direct vicinity of gastric tumors increased gradually and became linear as we proceeded away from the tumor. This suggests that loss of NIS expression may precede microscopically identifiable morphological changes. One could speculate that NIS expression in the apparently normal gastric mucosa could be used to define the true healthy margin, thus becoming a potentially useful indicator to decrease local/anastomotic recurrences.
###end p 33
###begin p 34
###xml 320 323 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 326 328 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
In junctional and fundus-type columnar metaplasia Barrett mucosa, NIS expression was intact; in contrast, in Barret mucosa with intestinalization, NIS expression was absent. A similar phenomenon was observed in hyperplastic gastric polyps with intestinal metaplasia. These data provide the molecular explanation for the 99mTcO4 -scintigraphic results from 30 years ago[16-18,20,21].
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Taken together, our findings underscore the prognostic and diagnostic significance of the absence of NIS expression in gastric alterations when intestinalization or cancer occurs. This is especially true in Barrett metaplasia, since the junctional and fundus-type metaplasias, in which NIS is normally expressed, pose a much lower risk of malignant transformation than intestinal metaplasia, which exhibits no NIS expression and gives rise to a higher number of dysplastic alterations and adenocarcinomas even in small (i.e., <3-cm) lesions[34]. In conclusion, this research suggests that the introduction of NIS immunohistochemical tests in gastric mucosa samples may be of considerable diagnostic value in Barrett esophageal and gastric polyps to evaluate intestinal metaplasia, and as an additional early molecular marker in the diagnosis of precancerous or/and cancerous gastroesophageal lesions.
###end p 36
###begin title 37
Competing interests
###end title 37
###begin p 38
The author(s) declare that they have no competing interests.
###end p 38
###begin title 39
Authors' contributions
###end title 39
###begin p 40
OD and NC conceived the study, AA, OD and NC designed the study and drafted the manuscript, OD and NC generated the NIS Abs and established the protocol for NIS immunohistochemistry, AA and ASZ collected the samples and carried out immunohistochemistries, OD and MP performed immunoblots, IW performed pertechnetate imaging. All authors read and approved the final manuscript.
###end p 40
###begin title 41
Pre-publication history
###end title 41
###begin p 42
The pre-publication history for this paper can be accessed here:
###end p 42
###begin p 43

###end p 43
###begin title 44
Acknowledgements
###end title 44
###begin p 45
Grant support: NIH DK-41544 (NC).
###end p 45
###begin article-title 46
Cloning and characterization of the thyroid iodide transporter
###end article-title 46
###begin article-title 47
###xml 15 20 <span type="species:ncbi:9606">human</span>
Cloning of the human sodium Iodide symporter
###end article-title 47
###begin article-title 48
The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance
###end article-title 48
###begin article-title 49
Extrathyroidal iodide concentrating mechanims
###end article-title 49
###begin article-title 50
###xml 12 17 <span type="species:ncbi:9606">human</span>
Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa
###end article-title 50
###begin article-title 51
The mammary gland iodide transporter is expressed during lactation and in breast cancer
###end article-title 51
###begin article-title 52
Expression of Na+/l-symporter and Pendred syndrome genes in trophoblast cells
###end article-title 52
###begin article-title 53
###xml 51 61 <span type="species:ncbi:10141">guinea-pig</span>
###xml 63 69 <span type="species:ncbi:9986">rabbit</span>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Active iodide transport across the placenta of the guinea-pig, rabbit and rat
###end article-title 53
###begin article-title 54
Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues
###end article-title 54
###begin article-title 55
###xml 67 72 <span type="species:ncbi:9606">human</span>
Expression, exonintron organization, and chromosome mapping of the human sodium iodide symporter
###end article-title 55
###begin article-title 56
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues
###end article-title 56
###begin article-title 57
###xml 42 47 <span type="species:ncbi:9606">human</span>
Regulation and tissue distribution of the human sodium iodide symporter gene
###end article-title 57
###begin article-title 58
###xml 74 79 <span type="species:ncbi:9606">human</span>
Na(+)/l(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues
###end article-title 58
###begin article-title 59
Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections
###end article-title 59
###begin article-title 60
###xml 65 70 <span type="species:ncbi:9606">human</span>
Immunohistochemical analysis of Na+/l- symporter distribution in human extra-thyroidal tissues
###end article-title 60
###begin article-title 61
The use of 99 m Tc to detect gastric malignancy
###end article-title 61
###begin article-title 62
[Physiological and pathological findings in the use of technetium 99 m for gastric scintigraphy]
###end article-title 62
###begin article-title 63
[The value of stomach scintigraphy with technetium 99 m as a routine diagnostic procedure]
###end article-title 63
###begin article-title 64
I-131 total-body scan: localization of disseminated gastric adenocarcinoma. Case report and survey of the literature
###end article-title 64
###begin article-title 65
Radioisotope scintigraphy in diagnosis of Barrett's esophagus
###end article-title 65
###begin article-title 66
Diagnosis of Barrett's esophagus by pertechnetate scintigraphy
###end article-title 66
###begin article-title 67
Rapid communication: predominant intracellular overexpression of the Na(+)/l(-) symporter (NIS) in a large sampling of thyroid cancer cases
###end article-title 67
###begin article-title 68
Characterization of the thyroid Na+/l- symporter with an anti-COOH terminus antibody
###end article-title 68
###begin article-title 69
Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology
###end article-title 69
###begin article-title 70
Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin
###end article-title 70
###begin article-title 71
###xml 82 85 <span type="species:ncbi:10116">rat</span>
The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription
###end article-title 71
###begin article-title 72
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands
###end article-title 72
###begin article-title 73
Thyroid Na+/l-symporter. Mechanism, stoichiometry, and specificity
###end article-title 73
###begin article-title 74
###xml 13 17 <span type="species:ncbi:9615">dogs</span>
Haldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion
###end article-title 74
###begin article-title 75
Stomach NO synthesis
###end article-title 75
###begin article-title 76
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori is killed by nitrite under acidic conditions
###end article-title 76
###begin article-title 77
Effects of ascorbic acid, glutathione, thiocyanate, and iodide on antimicrobial activity of acidified nitrite
###end article-title 77
###begin article-title 78
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori persistence: biology and disease
###end article-title 78
###begin article-title 79
Reflux, Barrett's oesophagus and adenocarcinoma: burning questions
###end article-title 79
###begin title 80
Figures and Tables
###end title 80
###begin p 81
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NIS expression in different tissues</bold>
###xml 37 38 37 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
NIS expression in different tissues. A: Radioiodide accumulation in NIS-expressing human tissues (SG: salivary glands, T: thyroid, G: stomach) 2 hours after 99mTc-pertechnetate administration (5 mCi). B: Immunoblot analyses of human NIS expression in a Graves' thyroid (T), normal salivary glands (SG), and normal gastric mucosa (G). Total protein (50 mug) was electrophoresed into each lane; the nitrocellulose membrane was probed with 3 nM affinity-purified anti-human-NIS Ab as described in Materials and Methods. C-H: Immunohistochemical analyses of NIS expression in human iodide-concentrating tissues. C: Normal thyroid (original magnification: 400 x), D: Graves' thyroid, strong basolateral NIS staining of the follicular epithelial cells (original magnification: 1,000 x), E: Salivary gland (original magnification: 400 x), F: Basolateral NIS staining in the salivary ductal cells (original magnification: 1,000 x), G: Gastric mucosa (original magnification: 400 x), H: Basolateral NIS staining of the gastric mucin-secreting cells (original magnification: 1,000 x).
###end p 81
###begin p 82
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunoblot analysis of gastric NIS expression in human gastric tumors (T) and normal peritumoral tissues (N)</bold>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Immunoblot analysis of gastric NIS expression in human gastric tumors (T) and normal peritumoral tissues (N). A, B, and D: adenocarcinoma, C: MALT lymphoma.
###end p 82
###begin p 83
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemical analysis of NIS expression in human gastrointestinal tract</bold>
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 183 184 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 344 345 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 463 464 463 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 551 552 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 655 656 655 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 736 737 736 737 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 827 828 827 828 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 912 913 912 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 1012 1013 1012 1013 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 1157 1158 1157 1158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1255 1256 1255 1256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">m</bold>
###xml 1355 1356 1355 1356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">n</bold>
###xml 1415 1416 1415 1416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">o</bold>
###xml 1485 1486 1485 1486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p</bold>
###xml 1545 1546 1545 1546 <bold xmlns:xlink="http://www.w3.org/1999/xlink">q</bold>
###xml 1642 1643 1642 1643 <bold xmlns:xlink="http://www.w3.org/1999/xlink">r</bold>
###xml 1715 1716 1715 1716 <bold xmlns:xlink="http://www.w3.org/1999/xlink">s</bold>
###xml 1798 1799 1798 1799 <bold xmlns:xlink="http://www.w3.org/1999/xlink">t</bold>
###xml 1880 1881 1880 1881 <bold xmlns:xlink="http://www.w3.org/1999/xlink">v</bold>
###xml 1938 1939 1938 1939 <bold xmlns:xlink="http://www.w3.org/1999/xlink">w</bold>
###xml 2008 2009 2008 2009 <bold xmlns:xlink="http://www.w3.org/1999/xlink">x</bold>
###xml 2082 2083 2082 2083 <bold xmlns:xlink="http://www.w3.org/1999/xlink">y</bold>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Immunohistochemical analysis of NIS expression in human gastrointestinal tract. a: normal esophageal squamous epithelium (haematoxylin-eosin/HE/staining, original magnification 100x) b: normal esophageal squamous epithelium: negative for NIS expression (original magnification 100x) c: Barrett mucosa (HE staining, original magnification 100x) d: Barrett mucosa, junctional and fundus-type columnar metaplasia: NIS positive staining (original magnification 100x) e: Barrett mucosa with intestinal metaplasia (HE staining, original magnification 100x) f: Barrett mucosa with intestinal metaplasia: negative for NIS expression (original magnification 100x) g: squamous cell esophageal carcinoma (HE staining, original magnification 100x) h: squamous cell esophageal carcinoma: NIS negative staining (original magnification 100x) i: gastric carcinoma - signet ring cell - (HE staining, original magnification 200x) j: gastric carcinoma - signet ring cell - negative for NIS expression (original magnification 200x) k: on the border of the gastric adenocarcinoma, adjacent "normal" extratumoral mucosa: faint, focal NIS expression (original magnification 100x) I: at 1 cm from gastric adenocarcinoma: definite focal NIS staining (original magnification 400x) m: far from the gastric adenocarcinoma: strong, linear NIS expression (original magnification 400x) n: gastric polyp (HE staining, original magnification 100x) o: gastric polyp: NIS positive staining (original magnification 100x) p: gastric polyp (HE staining, original magnification 200x) q: gastric polyp with colon-type metaplasia: NIS negative staining (original magnification 200x) r: small bowel adenocarcinoma (HE staining, original magnification 100x) s: small bowel adenocarcinoma: NIS negative staining (original magnification 100x) t: normal large bowel mucosa: NIS negative staining (original magnification 100x) v: colon polyp (HE staining, original magnification 100x) w: colon polyp: NIS negative expression (original magnification 100x) x: adenocarcinoma of the colon (HE staining, original magnification 100x) y: adenocarcinoma of the colon: negative for NIS expression (original magnification 100x).
###end p 83
###begin p 84
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Immunoblot analysis of Na+/l- symporter protein expression in gastric tumors
###end p 84
###begin p 85
###xml 38 43 <span type="species:ncbi:9606">human</span>
NIS expression in normal and diseased human gastro-intestinal tissues
###end p 85
###begin p 86
* Samples obtained from the corresponding peritumoral tissues are shown in Table 3; however, they are included in the total number of samples in this table.
###end p 86
###begin p 87
NIS expression in gastrointestinal tumors and adjacent tissues
###end p 87
###begin p 88
(*gastro-esophageal junction)
###end p 88

